Correlation Between Sonnet Biotherapeutics and Clearmind Medicine

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Clearmind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Clearmind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Clearmind Medicine Common, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Clearmind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Clearmind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Clearmind Medicine.

Diversification Opportunities for Sonnet Biotherapeutics and Clearmind Medicine

0.46

Correlation Coefficient

Sonnet Biotherapeutics  Clearmind Medicine

Very weak diversification

The 3 months correlation between Sonnet and Clearmind is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Clearmind Medicine Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearmind Medicine Common and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Clearmind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearmind Medicine Common has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Clearmind Medicine go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Clearmind Medicine

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 0.88 times more return on investment than Clearmind Medicine. However, Sonnet Biotherapeutics Holdings is 1.13 times less risky than Clearmind Medicine. It trades about 0.02 of its potential returns per unit of risk. Clearmind Medicine Common is currently generating about 0.02 per unit of risk. If you would invest  144.00  in Sonnet Biotherapeutics Holdings on December 21, 2024 and sell it today you would lose (1.00) from holding Sonnet Biotherapeutics Holdings or give up 0.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  Clearmind Medicine Common

Sonnet Biotherapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Clearmind Medicine Common

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Clearmind Medicine Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearmind Medicine may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Sonnet Biotherapeutics and Clearmind Medicine

The main advantage of trading using opposite Sonnet Biotherapeutics and Clearmind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Clearmind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearmind Medicine will offset losses from the drop in Clearmind Medicine's long position.

The idea behind Sonnet Biotherapeutics Holdings and Clearmind Medicine Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.